SCHEMBL4627732

SCHEMBL4627732

CC(C)(C)OC(=O)NC(Cc1ccc2nc(Oc3ccc(Cl)cc3)ccc2c1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.53
CTSB P07858 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
PPARG P37231 2/20 0.48
PPARA Q07869 2/20 0.48
ITGB3 P05106 2/20 0.48
ITGA2B P08514 2/20 0.48
ACE P12821 1/20 0.46
CTSL P07711 1/20 0.44
SCN9A Q15858 3/20 0.44
ITGB1 P05556 2/20 0.44
ITGAV P06756 2/20 0.44
PTPN2 P17706 3/20 0.42
CDC25B P30305 3/20 0.42
KMT2A Q03164 1/20 0.41
CYP3A4 P08684 1/20 0.41
ITGA4 P13612 1/20 0.41
ITGB7 P26010 1/20 0.41
PTPN6 P29350 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3316020 0.92 CTSB (0.46) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4627618 0.92 PTPN1 (0.58) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4627526 0.86 ITGB1 (0.52) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4624438 0.85 PTPN1 (0.54) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL3317006 0.84 CTSS (0.54) PTPN1CTSBCTSSCTSKACE
SCHEMBL2290589 0.83 ITGB3 (0.62) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL2290585 0.83 ITGB3 (0.62) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4625765 0.83 PTPN1 (0.52) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4625464 0.82 PTPN1 (0.49) PTPN1CTSBCTSSCTSKPPARG
SCHEMBL4625259 0.81 ITGB1 (0.67) PTPN1ITGB3ITGB1ITGAVITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP claimed